Loading...
Ryman Healthcare Limited
RYHTY•PNK
Healthcare
Medical - Care Facilities
$7.05
$0.00(0.00%)
Ryman Healthcare Limited (RYHTY) Financial Performance & Income Statement Overview
Review Ryman Healthcare Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
16.14%
↑ 16.14%
Operating Income Growth
-116.48%
↓ 116.48%
Net Income Growth
-98.15%
↓ 98.15%
Operating Cash Flow Growth
21.32%
↑ 21.32%
Operating Margin
1.72%
↑ 1.72%
Gross Margin
4.13%
↑ 4.13%
Net Profit Margin
-11.98%
↓ 11.98%
ROE
-2.05%
↓ 2.05%
ROIC
0.11%
↑ 0.11%
Ryman Healthcare Limited (RYHTY) Income Statement & Financial Overview
Review Ryman Healthcare Limited's (RYHTY) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $365.15M | $333.86M | $316.67M | $290.18M |
| Cost of Revenue | $341.81M | $179.51M | $319.04M | $291.73M |
| Gross Profit | $23.34M | $154.35M | -$2.37M | -$1.55M |
| Gross Profit Ratio | $0.06 | $0.46 | -$0.007 | -$0.005 |
| R&D Expenses | $0.00 | $8.04M | $0.00 | $11.74M |
| SG&A Expenses | $0.00 | $115.78M | $0.00 | $0.00 |
| Operating Expenses | $0.00 | $123.81M | $67.51M | $66.87M |
| Total Costs & Expenses | $341.81M | $303.33M | $319.04M | $291.73M |
| Interest Income | $0.00 | $27.33M | $1.27M | $1.78M |
| Interest Expense | $0.00 | $0.00 | $21.70M | $186.02M |
| Depreciation & Amortization | $25.40M | $17.61M | $26.19M | $23.60M |
| EBITDA | $22.16M | -$241.81M | $191.33M | $22.05M |
| EBITDA Ratio | $0.06 | -$0.72 | $0.60 | $0.08 |
| Operating Income | $23.34M | -$5.39M | -$2.37M | -$1.55M |
| Operating Income Ratio | $0.06 | -$0.02 | -$0.007 | -$0.005 |
| Other Income/Expenses (Net) | $151.46M | -$138.79M | $145.81M | -$9.55M |
| Income Before Tax | $174.81M | -$144.18M | $143.44M | -$11.11M |
| Income Before Tax Ratio | $0.48 | -$0.43 | $0.45 | -$0.04 |
| Income Tax Expense | $80.44M | -$106.45M | -$43.25M | -$74.96M |
| Net Income | $94.36M | -$90.95M | $186.69M | $63.85M |
| Net Income Ratio | $0.26 | -$0.27 | $0.59 | $0.22 |
| EPS | $0.14 | -$0.26 | $0.27 | $0.11 |
| Diluted EPS | $0.14 | -$0.26 | $0.27 | $0.11 |
| Weighted Avg Shares Outstanding | $693.43M | $687.65M | $687.64M | $573.17M |
| Weighted Avg Shares Outstanding (Diluted) | $687.64M | $687.64M | $687.64M | $573.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan